|
Monday, February 28 — 8:00 AM — Convention Center Bridge Hall
Click on the numbers in parentheses to display abstracts.
Section B - HEMATOPATHOLOGY
Chaired by: Peter M. Banks and, James R.. Cook
| 8:00 |
FAK Expression is a Good Prognostic Marker in Diffuse Large Cell Lymphoma and is Associated with Germinal Center Phenotype
(1099)
F. Khanani, SH Khayyata, M. Kurrer, P. Sochacki, E Levi - Harper Hospital, Wayne State University, Detroit, MI; University Hospital, Zurich, Switzerland; John D. Dingell VA Medical Center, Wayne State University, Detroit, MI
|
| 8:15 |
Cox-2 Staining Is Correlated with Increased MIB-1 Fraction in Diffuse Large B Cell Lymphoma
(1170)
LK Sussman, J Teruya-Feldstein - Memorial Sloan-Kettering Cancer Center, New York, NY
|
| 8:30 |
PRDM1 Is a Tumor Suppressor Gene in Diffuse Large B-Cell Lymphomas
(1171)
W Tam, MF Gomez, A Chadburn, JW Lee, WC Chan, DM Knowles - Weill Medical College, Cornell Univ., New York, NY; Univ. of Nebraska Medical Center, Omaha, NE
|
| 8:45 |
PU.1 Binds to the BCL-6 Promotor and Is Co-Upregulated with Bcl-6 in Germinal Center B-Cell Development and Germinal-Center Cell-Derived B-Cell Lymphoma
(1174)
E Torlakovic, A Malecka, JH Myklebust, A Tierens, H-C Aasheim, JM Nesland, E Smeland, S Kvaloy, J Delabie - Royal University Hospital, Saskatoon, SK, Canada; The Norwegian Radium Hospital, Oslo, Norway;
|
| 9:00 |
Prognostic Significance of Germinal Center (GC) Phenotype for Outcome in Follicular Lymphoma
(1175)
E Torlakovic, N Bilalovic, R Golouh, JM Nesland - Royal Univ. Hospital, Saskatoon, SK, Canada; Univ. Hospital Sarajevo, Sarajevo, Bosnia and Herzegowina; Institute of Oncology, Ljubljana, Slovenia; The Norwegian Radium Hospital, Oslo, Norway
|
| 9:15 |
A Rapid and Comprehensive Real Time PCR Assay for the Detection and Characterization of BCL2/IGH Translocations in Follicular Lymphomas
(1162)
LB Smith, R Valdez, WG Finn, JA Thorson University of Michigan, Ann Arbor, MI - 9:30: RECESS, EXHIBITS, POSTER SESSION I
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
|
| 11:00 |
Molecular Diagnosis of Burkitt Lymphoma Using Gene Expression Profiling
(1067)
K Fu, S Dave, G Wright, DD Weisenburger, TC Greiner, G Ott, HK Muller-Hermelink, LM Rimsza, RM Braziel, RD Gascoyne, J Delabie, E Campo, ES Jaffe, M Chiorazzi, H Zhao, WC Chan, LM Staudt, The LLMP - Univ. of Nebraska Medical Center; NCI; Univ. of Wurzburg; Univ. of Arizona; Univ. of Oregon; British Columbia Cancer Agency; Norwegian Radium Hospital; Univ. of Barcelona
|
| 11:15 |
Flow Cytometric Comparison of Burkitt and CD10(+) Large B-Cell Lymphomas
(1098)
MV Kesler, Y Xu, NJ Karandikar, RW McKenna, SH Kroft - University of Texas Southwestern Medical Center, Dallas, TX
|
| 11:30 |
High Level of cdc2 Expression Detectable by Immunohistochemistry Correlates with Worse Clinical Outcome in Patients with Mantle Cell Lymphoma
(1086)
D Hui, T Reiman, J Hanson, A Belch, R Lai - University of Alberta, Edmonton, AB, Canada; Cross Cancer Institute, Edmonton, AB, Canada; Cross Cancer Institute, Edmonton, AB, Canada; University of Alberta, Edmonton, AB, Canada
|
| 11:45 |
MRNA Expression Profile of p53 Mutant or ATM Mutant Cases of Mantle Cell Lymphoma
(1077)
T Greiner, J Hacia, A Rosenwald, D Weisenburger, L Smith, E Jaffe, R Gascoyne, E Campo, K Mueller-Hermelink, G Ott, J Delabie, R Braziel, L Staudt, W Chan - Univ of Nebraska Medical Center, Omaha, NE; Univ of Southern California, Los Angeles, CA; Univ of Wurzburg, Wurzburg, Germany; National Cancer Institute, Bethesda, MD; British Columbia Cancer Agency, Vancouver, BC, Canada; Univ of Barcelona, Barcelona, Spain; Norwegian Radium Hospital, Oslo, Norway; Univ of Oregon, Portland, OR
|
|
|
